This article discusses adult health topics. Content is educational and science-based.
Tier 3

Premature Ejaculation: Evidence-Based Techniques and Treatment Options

Premature ejaculation is the most common male sexual dysfunction. Behavioral techniques, pelvic floor training, and medications all have clinical support.

7 min read

Premature ejaculation (PE) is the most common male sexual dysfunction, affecting an estimated 20–30% of men across age groups. Despite its prevalence, it is frequently under-discussed in medical settings and misunderstood as purely a psychological problem.

PE has both neurobiological and psychological components, and the most effective treatments address both. Multiple evidence-based approaches β€” behavioral, physical, and pharmacological β€” have genuine clinical support.

Defining Premature Ejaculation

The International Society of Sexual Medicine (ISSM) defines lifelong PE as ejaculation that always or nearly always occurs within approximately 1 minute of vaginal penetration, combined with the inability to delay ejaculation, and negative personal consequences such as distress or avoidance of sexual activity. [^althof2014]

Acquired PE (developing after a period of normal function) has a similar clinical definition but a different underlying cause profile β€” it is more likely to involve psychological factors, relationship changes, erectile dysfunction, or medical conditions than the neurobiological factors that drive lifelong PE.

Intravaginal ejaculatory latency time (IELT) β€” the time from penetration to ejaculation β€” is the standard clinical measurement. The 10th percentile in large population studies is approximately 1–2 minutes; median IELT is approximately 5–6 minutes.

Neurobiological Basis

Ejaculation is primarily controlled by the spinal ejaculatory generator, which is modulated by serotonergic (inhibitory) and dopaminergic (excitatory) pathways from the brain. [^waldinger2005] Lifelong PE is associated with a genetically determined low threshold for this reflex β€” meaning the ejaculatory system fires with less stimulation than average.

This serotonergic model explains why SSRIs and serotonin-targeting medications are effective treatments, and why the condition often has a familial pattern. It also explains why purely psychological approaches have limited efficacy for lifelong PE, while being more effective for acquired PE.

Behavioral Techniques

Stop-Start Method (Semans Technique)

The original behavioral technique, described by Semans in 1956, involves stimulating the penis to a high level of arousal, then stopping all stimulation until arousal decreases, then resuming. [^semans1956] Repeated practice trains the man to recognize and tolerate high levels of arousal without ejaculating.

Protocol:

  1. Stimulate until high arousal (just before the "point of no return")
  2. Stop completely; wait 30–60 seconds for arousal to decrease
  3. Resume stimulation
  4. Repeat 3–4 times per session before allowing ejaculation

This can be practiced solo initially, then with a partner. Requires consistent practice over 4–8 weeks to see meaningful change.

Squeeze Technique (Masters and Johnson)

A variation that adds physical pressure at the moment of stopping. When approaching ejaculatory threshold, the man or partner applies firm pressure to the frenulum area (where the glans meets the shaft on the underside) for 15–30 seconds. This reduces arousal more effectively than stopping alone for some men.

Evidence for behavioral techniques alone is modest β€” RCT data show improvement compared to no treatment, but effect sizes are smaller than pharmacological approaches and dropout rates are high without professional support. The combination of behavioral training with pharmacotherapy produces better outcomes than either alone.

Sensate Focus

A broader sex therapy approach that temporarily removes performance pressure by shifting attention to non-goal-directed physical sensation. Useful when performance anxiety is a significant component of acquired PE.

Pelvic Floor Training

The pelvic floor's role in ejaculatory control is underappreciated. The bulbocavernosus and ischiocavernosus muscles contract rhythmically during ejaculation. Voluntary control of these muscles can extend latency time.

A prospective trial by Pastore et al. assigned men with lifelong PE to pelvic floor muscle rehabilitation (12 weeks of supervised training) and measured IELT before and after. [^pastore2014] Results: mean IELT increased from 31.7 seconds at baseline to 146.2 seconds at 12 weeks β€” a nearly 5-fold improvement. A control group showed minimal change.

The mechanism: strengthening awareness and voluntary control of the bulbocavernosus muscle allows conscious modulation of the ejaculatory reflex.

Pelvic floor training protocol for PE:

  • Identify the target muscles (contract to stop urine flow mid-stream; this is the bulbocavernosus)
  • Practice isolated contractions: 3 sets of 10, holding 3–5 seconds each, twice daily
  • Progress to "reverse Kegels" (relaxation/lengthening exercises) which are equally important for PE management
  • At high arousal, voluntary relaxation of pelvic floor muscles can delay ejaculation

Results typically emerge after 8–12 weeks of consistent practice.

Pharmacological Options

Topical Anesthetics

Local anesthetics (lidocaine, prilocaine, or benzocaine) applied to the glans 10–20 minutes before intercourse reduce penile sensitivity, extending IELT. [^xin1997] Several controlled trials show significant improvement compared to placebo.

Available as cream, spray, or gel. Issues include:

  • Transfer to partner (requiring a condom or washoff before intercourse)
  • Some men find reduced sensation makes sex less enjoyable
  • Products with the lowest effective dose minimize these issues

A lidocaine/prilocaine spray (EMLA or equivalent) is the best-studied formulation.

SSRIs (Off-Label)

All SSRIs delay ejaculation as a side effect β€” which is a treatment advantage for PE. The most studied for PE include paroxetine (most potent effect), sertraline, fluoxetine, and citalopram. [^richardson2006]

Daily dosing: Taken consistently, SSRIs increase ejaculatory latency by 3–8 times over baseline in clinical trials. Effects are sustained with continued use.

On-demand dosing: Paroxetine and clomipramine taken 3–4 hours before sexual activity show meaningful improvement over baseline, though effects are smaller than daily dosing.

Side effects relevant to PE treatment: nausea (particularly early), reduced libido (can be a problem), and delayed or absent orgasm at high doses.

Dapoxetine (Where Available)

Dapoxetine is a short-acting SSRI developed specifically for on-demand PE treatment. [^mcmahon2011] It is approved in many European and Asian countries but not the United States. Taken 1–3 hours before sexual activity, it provides a transient serotonergic effect without the sustained systemic exposure of daily SSRIs.

Compared to daily SSRIs for PE, dapoxetine has similar efficacy for on-demand use with fewer systemic side effects.

Tramadol (Off-Label, Caution)

Tramadol, an opioid analgesic, also has serotonergic activity and has been studied for PE. It shows meaningful efficacy in trials. However, its opioid mechanism creates addiction risk that makes it inappropriate as a primary PE treatment. It should only be considered when other approaches have failed and under close medical supervision.

Erectile Dysfunction and PE

Acquired PE frequently co-occurs with erectile dysfunction. In this setting, the man ejaculates quickly partly because he is rushing to ejaculate before losing his erection β€” an adaptive response to unreliable erections. Treating the erectile dysfunction often resolves the acquired PE without direct PE treatment.

This distinction matters clinically: treating PE with SSRIs (which can worsen ED) in a man whose PE is secondary to ED will fail. The ED should be treated first.

Psychological and Relationship Factors

Performance anxiety, relationship stress, sexual guilt, and negative sexual self-concept all contribute to acquired PE and amplify distress in lifelong PE. Sex therapy addressing these factors produces better long-term outcomes than medication alone in acquired PE.

For lifelong PE, psychological therapy improves coping and reduces distress but does not substantially change IELT on its own β€” the neurobiological threshold is not modifiable through psychology alone.

Combined Approaches

The ISSM guidelines recommend that for most men, a combination of pharmacotherapy (to quickly improve IELT) and behavioral/psychological techniques (to build lasting skills and reduce anxiety) produces the best outcomes. [^althof2014] Medication alone without skill development leads to recurrence when medications are stopped.

Bottom Line

PE is one of the most treatable sexual dysfunctions. Behavioral techniques, pelvic floor training, topical anesthetics, and SSRIs all have clinical evidence behind them. The best approach depends on whether PE is lifelong (neurobiologically driven, responds best to medication or pelvic floor training) or acquired (often psychological, responds to behavioral and relationship interventions). Combined approaches outperform either pharmacology or psychology alone for most men.

References

  1. Waldinger MD. The neurobiological approach to premature ejaculation. Journal of Urology (2002). PubMed:12352388
  2. Althof SE, McMahon CG, Waldinger MD, et al.. An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation. Journal of Sexual Medicine (2014). PubMed:25273865
  3. Semans JH. Premature ejaculation: a new approach. Southern Medical Journal (1956). PubMed:13380207
  4. Pastore AL, Palleschi G, Fuschi A, et al.. Pelvic floor muscle rehabilitation for patients with lifelong premature ejaculation: a novel therapeutic approach. Therapeutic Advances in Urology (2014). PubMed:24883107
  5. McMahon CG. Dapoxetine: a new option in the medical management of premature ejaculation. Therapeutic Advances in Urology (2012). PubMed:23205059
  6. Xin ZC, Choi YD, Rha KH, Choi HK. Topical anesthetic agents for premature ejaculation. Asian Journal of Andrology (1997). PubMed:9477186
  7. Richardson D, Goldmeier D. The role of serotonin in premature ejaculation. International Journal of STD and AIDS (2005). PubMed:16268964

Related Articles